Covid-19 Drug Hopes & Rebounding Oil Supports Stocks. ECB In Focus

The FTSE is pointing to a strong start on the open as sentiment remains upbeat on signs of progress in treating coronavirus and as oil continues its advance.

Uptrend 2

The FTSE is pointing to a strong start on the open as sentiment remains upbeat on signs of progress in treating coronvirus and as oil continues its advance.

Optimism continues to drive the markets this time driven by encouraging results from a covid-19 treatment trial. Comments by Anthony Fauci, that Gilead’s antiviral remdesivir will become the standard care for coronavirus infections after early results from a trial showed hat it aided a speedy recovery. Any encouraging news on covid-19 drugs or vaccines will boost sentiment. The market is fully aware that any cure or prevention will see economies bounce back to pre-coronavirus form rapidly. Even without a cure, the market is happy to settle for control of the spread of coronavirus. With regards to the spread, we are definitely in a better place than a month ago, although it is still far to early to sing any victory song.

Oil extends gains
Oil prices continue to rise on Thursday, building g on big gains from the previous session amid optimism that the crude glut isn’t as bad as first thought and amid signs that fuel demand is slowing stating to pick up as states and countries ease out of lock down. Crude for June delivery jumped 22% in the previous session and is trading an additional 13% higher in early trade on Thursday, having hit a high of $17.73 per barrel. 

Whilst we still expect volatility in the oil market, there is a sense that the worst is over and that there is at least a floor in place. With countries gradually reopening, demand will continue to grind higher. The biggest risk for the price of oil would be a second wave of infections forcing countries back into lock down. Germany faces the prospect of having to restore stricter lockdown measures as its number and rate of coronavirus infections grew again. Whilst this risk remains very real we can expect to see process oscillate around these levels. Any moves to increase storage in he US, or further output cuts by OPEC could see the floor that is forming raised.

EZ GDP & ECB under the spotlight
Today is a busy day on the economic calendar with a slew of data from the eurozone due, including German retail sales, Eurozone inflation and German unemployment numbers. However, the most closely watched with be Eurozone GDP figures and the ECB monetary policy announcement. 

EUR/USD is holding steady ahead of Eurozone Q1 GDP, which is forecast to reveal a -3.3% contraction, following 1% growth in Q4 2019. The data will reflect the beginning of lock down which started in Italy in the second week of March. Recently data has had a tendency to surprise to the downside so a weaker reading could well be on the cards.

Following the failure of EU leaders to agree to an economic recovery plan for the bloc, the ball is firmly back in the ECB’s court. The ECB are expected to expand the PEPP QE programme, most likely with “fallen angels” and possibly going as far as the Fed to include junk bonds. Expectations are rising high. Failure to act could drag on the Euro dragging it back towards $1.08

More from Indices

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.

Open an Account